Sign in

    Manish Pal

    Research Analyst at MHP Capital

    Manish Pal is a Research Analyst at MHP Capital, specializing in equity research with direct company coverage exemplified by his work on XBiotech. His public track record indicates participation in earnings call Q&As, demonstrating focused engagement with covered companies, though quantifiable investment performance metrics or industry rankings are not currently available. Pal's prior employment history and precise start date at MHP Capital have not been publicly detailed, nor are there records of previous roles at other financial institutions. Likewise, information regarding his FINRA registration or specific securities licenses is not available from public sources.

    Manish Pal's questions to XBiotech (XBIT) leadership

    Manish Pal's questions to XBiotech (XBIT) leadership • Q2 2016

    Question

    Manish Pal of MHP Capital inquired about the timeline for the European disposition of Xilonix, seeking confirmation of a Q4 date. He also asked for clarification on the shift from an expedited to a standard review process and questioned the company's pipeline for new partnership opportunities.

    Answer

    Founder, President & CEO John Simard confirmed the Q4 timeline for the European disposition. He explained the review process change was due to a different regulatory group handling the registration, which needed time to review the novel study design. Regarding partnerships, Simard noted that several discussions are ongoing for strategic fits that support the company's long-term, self-sufficient model.

    Ask Fintool Equity Research AI